Jiangsu Hengrui Pharmaceuticals’ License Agreement With Elevar Therapeutics

Cooley advised Jiangsu Hengrui Pharmaceuticals on the deal.Jiangsu Hengrui Pharmaceuticals (“Hengrui”), a global pharmaceutical company focused on scientific and technological innovation, signed a global license agreement (excluding…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now